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Brazil was the first developing country to provide free, universal access to antiretroviral
treatment for AIDS patients. The Brazilian experience thus provides the first evidence regarding
the impact of such treatment on the survival of perinatally acquired AIDS cases in the developing
world. Material and Methods: This retrospective cohort study used medical record reviews to
examine characteristics and trends in the survival of a representative sample of 914 perinatally
acquired AIDS cases in 10 Brazilian cities diagnosed between 1983 and 1998. Results: Survival
time increased steadily and substantially. Whereas half of the children died within 20 months of
diagnosis at the beginning of the epidemic, 75% of children diagnosed in 1997 and 1998 were
still alive after four years of follow-up. Conclusions: Advances in management and treatment have
made a great difference in the survival of Brazilian children with AIDS. These results argue
strongly for making such treatment available to children in the entire developing world.
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Monitoring trends in survival for AIDS patients
is important for several reasons. In addition to
providing prognostic information and a basis for
health services planning, survival time is a key
indicator of the impact of medical care. Enhanced
overall survival is the litmus test of effectiveness for
new treatment approaches.
Many recent studies have demonstrated substantial
improvement in survival among both adult and
pediatric patients with HIV infection in developed
countries, where antiretroviral treatment is generally
available [1-3]. However survival time has remained
poor in developing countries that do not provide such
treatment. Brazil was the first developing country to
provide free, universal access to antiretroviral
treatment (ART) through its national health care
system. Pneumocystis carinii prophylaxis became
available in 1992 and monotherapy with AZT began
in 1994. This was followed by double antiretroviral
treatment in 1997 and triple therapy, including
protease inhibitors, in 1998. Since then, new
treatments and laboratory tests for HIV infection have
become available in Brazil at about the same time as
in developed countries.
While some have questioned whether ART can be
effective in a developing country that lacks the health
infrastructure of richer countries [4], survival time has
increased substantially among adult Brazilian AIDS
patients [5]. No previous study has examined the
impact of universal access to ART on survival among
pediatric AIDS patients in Brazil or any other
developing country. We conducted a study of
perinatally-acquired AIDS cases in 10 Brazilian cities
to examine trends in survival.
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Materials and Methods
We examined AIDS cases in persons less than 13
years old listed in the Brazilian national AIDS registry
as of December 31, 2000, with reported dates of
diagnosis between 1983 (the year that the first case
was diagnosed) and December 31, 1998. The first
stage of sampling involved the purposive selection of
10 Brazilian cities: São Paulo, Rio de Janeiro, Porto
Alegre, Ribeirão Preto, Recife, Santos, Campinas,
Brasília, Belém, and São José do Rio Preto. The sample
included the two largest cities in both population and
number of pediatric AIDS cases, São Paulo and Rio
de Janeiro, both in the southeastern region of the
country. It also included the city with the largest number
of reported cases from each of Brazil’s other four
macroregions (Belém, Recife, Brasilia, and Porto
Alegre) plus three medium-sized cities with high rates
of AIDS (Santos, Campinas, and Riberao Preto).
Overall, these 10 cities accounted for approximately
60% of all reported pediatric AIDS cases in Brazil
during the period of study.
Of the 3,031 reported cases in these cities, we
excluded 206 attributed to transfusion, 136 in
hemophiliacs, and 9 attributed to sexual transmission
or injected drug use. The remaining 2,680 had been
reported as perinatal transmission or as unknown
transmission. Based on sample size estimates for
adequate statistical power, we randomly selected 1,268
of the 2,680 for medical record reviews. Of these,
1,065 records were located and contained sufficient
information for review. Additional exclusions included
60 cases that on review did not meet the official Brazilian
pediatric AIDS diagnostic criteria in effect at the time
[6-8] or did not do so until after December 31, 1998,
26 duplicate cases, and 20 with uncertain dates. Of
121 cases originally reported as “unknown,” 76 were
reclassified as perinatal transmission based on review
and were included in the study; the remaining 45 were
excluded. This left 914 cases for analysis.
Medical records were reviewed by abstracters who
received standardized training in study procedures.
Record reviews took place between May 2000 and
January 2002. Date of diagnosis was reassessed based
on the AIDS diagnostic criteria in effect at the time of
diagnosis. Date of death was established by medical
record review and/or by local mortality data, when
available. For patients not known to have died, the
date of censor was their last recorded clinic visit. Data
were entered using Excel 97 [9] and analyzed using
STATA version 7.0 [10]. Curves of survival from date
of AIDS diagnosis based on all-cause mortality were
produced using the Kaplan-Meier method.
Comparisons of survival time used the log-rank test.
This study received clearance from the ethical review
board of the Sao Paulo State STD/AIDS Program
following standards of the National Committee on
Research Ethics.
Results
Slightly over half of the 914 cases were female (Table
1). The number of cases diagnosed each year was fairly
steady after 1988, with only 16 cases diagnosed in
1987 or earlier. The most common diagnoses were
bacterial infections and Pneumocystis carinii
pneumonia. About 75% received some form of ART.
This proportion was higher among the recent cases,
with almost all diagnosed in 1997 and 1998 receiving
combination therapy.
Survival increased progressively among the more
recently diagnosed cases (p < 0.001, Figure 1). Median
survival for cases diagnosed before 1988 was 20
months. This increased to 24 months for cases
diagnosed between 1988 and 1992 and to 50 months
for cases diagnosed from 1993 to 1994. Median
survival could not be calculated for the more recently
diagnosed cases, because more than half were still living
by the end of follow-up, but continuing improvement
in survival has been evident. Over 75% of cases were
still alive four years after diagnosis among cases
diagnosed in 1997 and 1998, the most recent group
studied.
We examined trends in age at AIDS diagnosis.
Median age gradually increased from 14 months for
cases diagnosed before 1988 to 19 months for cases
diagnosed in 1997-1998.
Pediatric AIDS Survival in Brazil
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Survival after diagnosis according to year of diagnosis
Table 1. Characteristics of 914 cases of perinatally transmitted AIDS in Brazil
Figure 1. Survival after AIDS diagnosis among 914 cases of perinatally transmitted HIV in Brazil by year of
AIDS diagnosis.
Pediatric AIDS Survival in Brazil
Sex
Female 461
Male 453
Year of diagnosis
1983 – 1987 16
1988 – 1992 265
1993 – 1994 196
1995 – 1996 221
1997 – 1998 216
Most common presenting diagnoses*
Multiple bacterial infections 519
Pneumocystis carinii pneumonia 193
Bacterial meningitis or sepsis 143
Interstitial lymphocytic pneumonia 107
Received antiretroviral treatment
Yes 682
No 207
Unknown 25
*Multiple presenting diagnoses possible.
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Discussion
There was substantial improvement in survival
among Brazilian children with perinatally transmitted
AIDS. Other studies have shown similar increases in
survival, but the degree of improvement and recent
levels of survival achieved are difficult to compare. Most
reports of survival time among perinatally-acquired
AIDS cases are based on cohorts of HIV-infected
children who were identified at birth or soon thereafter.
Survival time is usually calculated from birth or date of
HIV diagnosis rather than from date of meeting AIDS
diagnostic criteria, leading to longer reported survival.
For example, survival to age five of Canadian children
infected perinatally increased from 72% for those born
in 1992-1995 to 92% for those born in 1996 [11]. In
the United States, survival to age five increased from
72% to 83% when comparing children born before
and after 1994 [12].
Our study was based on national AIDS reporting
data and thus has the advantage of being representative
of the general Brazilian population. But because cases
were not reported until after AIDS was diagnosed, we
are only able to provide unbiased estimates of survival
starting from this point. Although adding median age of
AIDS diagnosis to median survival after diagnosis gives
a rough estimate of median survival from birth, this
remains biased to the extent that infected children who
have gone undiagnosed or who have not yet met AIDS
diagnostic criteria are not included in the denominator.
This may change in the future because screening to
prevent and detect perinatal transmission of HIV has
now become the norm, and Brazil is implementing a
registry of all HIV-infected children. Comparable
national data on survival from date of AIDS diagnosis
in perinatally acquired cases have been reported from
the United States. Among cases diagnosed in 1998,
survival to 36 months was 87% [13]. Our data indicate
survival approaching similar levels in the most recently
diagnosed group of Brazilian children.
Our study has many potential limitations. While the 10
cities selected for this study are geographically
representative and account for the majority of reported
pediatric AIDS cases in Brazil, it is possible that
underreporting of cases may be higher and that both
absolute survival and the recent improvement in survival
may be lower outside of these major epicenters.
Underreporting of AIDS cases is estimated to be relatively
low in Brazil [14], but unreported cases may have shorter
survival, as might the 16% of cases in our original sample
for which we were unable to obtain information. While
these factors could cause an overestimate of survival, they
would not explain the secular increase in survival that was
observed, unless the magnitude of any such bias increased
substantially over time.
One factor that might affect observed survival time is
earlier diagnosis if patients were diagnosed earlier rather
than living longer. The case definition for AIDS in Brazil
was changed in 1994 to become more sensitive, and
CD4 testing became generally available in 1997. On the
other hand, improved early treatment and prophylaxis
for mother and child would be expected to delay
progression to AIDS. Our data indicate that the net effect
of these changes has been a slight increase in average
age at diagnosis of AIDS. This would not have caused
the longer survival after AIDS diagnosis that we observed;
on the contrary, it indicates that improvement in survival
from birth has been even greater.
The Brazilian experience is encouraging in many
ways. It demonstrates that it is possible for a developing
country to establish an effective system for providing
free, universal access to ART. It also demonstrates that
such care, even in a country that lacks an ideal health
infrastructure, can make a substantial difference in
survival. Since the years covered by this study, Brazil
has made great progress in reducing perinatal
transmission of HIV, and the number of new cases of
perinatally-acquired AIDS is falling [15]. There is good
reason to believe that remaining cases will experience
further improvements in survival. We also hope that
children elsewhere in the developing world will gain
access to the benefits of life-sustaining treatment.
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